High-sensitivity troponin I as a predictor of left ventricular dysfunction in the use of cardiotoxic anticancer agents for breast cancer in patients with predominantly low and moderate risk of cardiotoxicity

High-sensitivity troponin I as a predictor of left ventricular dysfunction in the use of cardiotoxic anticancer agents for breast cancer in patients with predominantly low and moderate risk of cardiotoxicity

Aim. To study the significance of monitoring high-sensitivity troponin I (hs-cTnI) for predicting anthracycline-induced left ventricular (LV) dysfunction in the treatment of breast cancer in patients with moderate and low risk of cardiotoxicity (CT).Material and methods. The study involved 49 patien...

Cijeli opis

Bibliografski detalji
Glavni autori: V. D. Levina, M. G. Poltavskaya, P. Sh. Chomakhidze, A. A. Meshcheryakov, L. V. Bolotina, T. I. Deshkina, D. S. Valiulina, A. N. Gerasimov, O. V. Andreeva, A. A. Shmeleva, Z.Z.A. Fashafsha, A. R. Levshina, V. P. Sedov
Format: Članak
Jezik:Russian
Izdano: «FIRMA «SILICEA» LLC 2022-12-01
Serija:Российский кардиологический журнал
Teme:
cardiotoxicity
anthracyclines
chemotherapy
left ventricular dysfunction
troponin
breast cancer
Online pristup:https://russjcardiol.elpub.ru/jour/article/view/5210

Internet

https://russjcardiol.elpub.ru/jour/article/view/5210

Slični predmeti